Green Cross Corporation Logo

Green Cross Corporation

006280 | KO

Overview

Corporate Details

ISIN(s):
KR7006280002
LEI:
Country:
South Korea
Address:
경기도 용인시 기흥구 이현로30번길 107(보정동), 용인시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-22 00:00
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
Korean 13.2 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 4.2 MB
2025-08-05 00:00
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
Korean 25.5 KB
2025-08-01 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.0 KB
2025-06-02 00:00
Governance Information
기업지배구조보고서공시
Korean 4.2 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 3.2 MB
2025-04-30 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.0 KB
2025-04-08 00:00
Regulatory Filings
투자판단관련주요경영사항
Korean 8.5 KB
2025-04-08 00:00
Management Reports
[기재정정]장래사업ㆍ경영계획(공정공시)
Korean 14.0 KB
2025-03-31 00:00
Management Reports
[기재정정]장래사업ㆍ경영계획(공정공시)
Korean 11.7 KB
2025-03-27 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 50.2 KB
2025-03-26 00:00
AGM Information
정기주주총회결과
Korean 19.8 KB
2025-03-18 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 717.7 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 19.6 KB
2025-03-13 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.8 KB

Automate Your Workflow. Get a real-time feed of all Green Cross Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Green Cross Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Green Cross Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ALNYLAM PHARMACEUTICALS, INC. Logo
Pioneering RNAi gene-silencing therapies for rare genetic and cardiometabolic diseases.
United States of America
ALNY
Alpha Cognition Inc. Logo
Develops and commercializes novel treatments for neurodegenerative diseases like Alzheimer's and ALS.
United States of America
ACOG
Alpha Teknova, Inc. Logo
Manufactures critical reagents for biopharma, scaling from research to GMP manufacturing.
United States of America
TKNO
ALTERITY THERAPEUTICS LTD Logo
Developing therapies for Parkinsonian disorders and MSA by inhibiting protein aggregation.
United States of America
ATHE
Altimmune, Inc. Logo
Developing novel peptide therapeutics for obesity, liver, and cardiometabolic diseases.
United States of America
ALT
Alto Neuroscience, Inc. Logo
Developing precision medicines for depression and schizophrenia using a brain biomarker platform.
United States of America
ANRO
ALUMIS INC. Logo
Develops targeted oral therapies for immune-mediated diseases using precision immunology.
United States of America
ALMS
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg
ALVO
ALX ONCOLOGY HOLDINGS INC Logo
Clinical-stage firm developing CD47 inhibitors for hematologic and solid tumors.
United States of America
ALXO
Alzamend Neuro, Inc. Logo
Developing lithium & vaccine therapies for neurodegenerative & psychiatric disorders.
United States of America
ALZN

Talk to a Data Expert

Have a question? We'll get back to you promptly.